vivoVerse
PrivateLast Round
Grant
Jul 9, 2024
Total Funding Raised
$4.08M
Company Overview
vivoVerse is a biotechnology company that provides a high-throughput drug screening and toxicology platform using microfluidics, automated imaging, and AI-driven analysis of C. elegans models.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
vivoVerse Comparables
Compare vivoVerse with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NemaLife | 90% | |
| Phylumtech S.A. | 83% | |
| Magnitude Biosciences | 83% | |
vivoVerse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2024 | ||||
| Grant | Aug 5, 2023 | ||||
| Grant | Jul 8, 2020 | ||||
| Grant | Jul 9, 2019 | ||||
| Grant | Oct 9, 2018 | ||||
Accelerator | Feb 21, 2018 |
Key People
Founding team and executive leadership
vivoVerse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassChallenge Israel | Accelerator |
| National Institute of Environmental Health Sciences | Grant |
| National Institute of Mental Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2025
Grew 23% QoQ, from 13 to 16 employees.
- Jul 9, 2024
Received grant from National Institute of Environmental Health Sciences.
vivoVerse Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about vivoVerse's valuation, stock price, and market status.